Shivalik Rasayan

Why is Shivalik Rasayan Ltd falling/rising?

As of 18-Aug, Shivalik Rasayan Ltd's stock price is at 242.90, down 4.05%. The stock has significantly underperformed, with a year-to-date decline of 31.74% and a 52.19% drop over the past year, indicating a bearish trend despite increased investor participation.

As of 18-Aug, Shivalik Rasayan Ltd's stock price is falling, currently at 242.90, which reflects a decrease of 10.25 or 4.05%. The stock has been underperforming, having lost 6.22% over the past week and 8.84% in the last two days alone. It opened with a loss of 3.18% today and reached an intraday low of Rs 240.65, marking a decline of 4.94%. <BR><BR>Additionally, the stock's performance has been poor over longer periods, with a year-to-date decline of 31.74% and a staggering 52.19% drop over the past year. Although the stock is currently trading above its 50-day moving average, it is below the 5-day, 20-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a rise in investor participation, with delivery volume increasing by 7.92% against the 5-day average, the overall sentiment remains negative, contributing to the stock's decline.

Which are the latest news on Shivalik Rasayan?

Should I buy, sell or hold Shivalik Rasayan Ltd?

Who are in the management team of Shivalik Rasayan?

The management team of Shivalik Rasayan includes Rahul Bishnoi (Chairman), S K Singh (Vice Chairman & Whole Time Director), Vimal Kumar Shrawat (Managing Director), and several other directors and independent directors responsible for the company's operations and strategic direction.

The management team of Shivalik Rasayan includes the following individuals:<BR><BR>1. **Rahul Bishnoi** - Chairman<BR>2. **S K Singh** - Vice Chairman & Whole Time Director<BR>3. **Ashwani Kumar Sharma** - Director<BR>4. **Harish Pande** - Independent Director<BR>5. **Kailash Gupta** - Independent Director<BR>6. **Arun Kumar** - Independent Director<BR>7. **Akshay Kant Chaturvedi** - Executive Director<BR>8. **Sanjay Bansal** - Director<BR>9. **Sumita Dwivedi** - Independent Director<BR>10. **Parul Choudhary** - Company Secretary<BR>11. **Sangeeta Bishnoi** - Independent Director<BR>12. **Ravi Kumar Bansal** - Independent Director<BR>13. **Vimal Kumar Shrawat** - Managing Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

What does Shivalik Rasayan do?

Shivalik Rasayan Ltd is a manufacturer of organophosphate insecticides in the pesticides and agrochemicals industry, with a market cap of INR 423 Cr. As of March 2026, it reported net sales of 103 Cr and a net profit of 5 Cr.

Overview:<BR>Shivalik Rasayan Ltd is a manufacturer of Organophosphate Insecticides operating in the Pesticides & Agrochemicals industry, categorized as a Micro Cap company.<BR><BR>History:<BR>Shivalik Rasayan Limited was incorporated on 16 March 1979. The company acquired 44.12% equity shares of M/s Medicamen Biotech Limited in 2016 and took over full management control on 1st January 2016. The latest quarterly results reported net sales and profit for March 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 103 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 5 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 423 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 35.00 <BR>Industry P/E: 44 <BR>Dividend Yield: 0.19% <BR>Debt Equity: 0.13 <BR>Return on Equity: 1.98% <BR>Price to Book: 0.71 <BR><BR>Contact Details:<BR>Address: Village Kolhupani, P O Chandanwari Dehradun UTT : 248007 <BR>Tel: 91-0135-2772038/2773429 <BR>Email: srl@vsnl.com/srl@airtelmail.in <BR>Website: http://www.shivalikrasayan.in

Who are the peers of the Shivalik Rasayan?

Shivalik Rasayan's peers include Dharmaj Crop, Heranba Inds, Best Agrolife, Super Crop Safe, Bhaskar Agrochem, Crop Life Science, Aristo Bio-Tech, and Dhansa Labs. In terms of management risk, Shivalik Rasayan has a below-average rating, with a 1-year return of -48.92%, better than Heranba Inds but worse than Super Crop Safe at 16.98%.

Peers: The peers of Shivalik Rasayan are Dharmaj Crop, Heranba Inds, Best Agrolife, Super Crop Safe, Bhaskar Agrochem, Crop Life Scienc, Aristo Bio-Tech, and Dhansa Labs.<BR><BR>Quality Snapshot: Excellent management risk is observed at Best Agrolife and Bhaskar Agrochem, while Average management risk is found at Dharmaj Crop, Heranba Inds, Crop Life Scienc, and Aristo Bio-Tech. Below Average management risk is noted for Shivalik Rasayan, Super Crop Safe, Dhansa Labs, and the rest. Growth is rated as Good for Dharmaj Crop, Average for Bhaskar Agrochem and Aristo Bio-Tech, and Below Average for Heranba Inds, Best Agrolife, Shivalik Rasayan, Super Crop Safe, Crop Life Scienc, and Dhansa Labs. Capital Structure is Excellent for Shivalik Rasayan, Good for Dharmaj Crop, Average for Heranba Inds, Best Agrolife, Aristo Bio-Tech, and the rest, and Below Average for Super Crop Safe, Bhaskar Agrochem, and Dhansa Labs.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Super Crop Safe at 16.98%, while the peer with the lowest is Heranba Inds at -50.97%. Shivalik Rasayan's 1-year return is -48.92%, which is better than Heranba Inds but worse than Super Crop Safe. Additionally, the six-month return is negative for Heranba Inds, Bhaskar Agrochem, and Dhansa Labs.

How big is Shivalik Rasayan?

As of 14th August, Shivalik Rasayan Ltd has a market capitalization of 414.00 Cr, with net sales of 368.01 Cr and a net profit of 11.88 Cr over the latest four quarters. Shareholder's funds are 536.24 Cr, and total assets are valued at 727.73 Cr as of March 2025.

As of 14th August, <BR><BR>Market Cap: Shivalik Rasayan Ltd has a market capitalization of 414.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 368.01 Cr, while the sum of Net Profit for the same period is 11.88 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds stand at 536.24 Cr, and Total Assets are valued at 727.73 Cr.

When is the next results date for Shivalik Rasayan Ltd?

The next results date for Shivalik Rasayan Ltd is 14 August 2026.

The next results date for Shivalik Rasayan Ltd is scheduled for 14 August 2026.

Are Shivalik Rasayan Ltd latest results good or bad?

Shivalik Rasayan Ltd's latest results show strong revenue growth with a 67.78% increase in net profit and a 48.18% rise in net sales, but concerns remain due to declining operating margins and a low return on equity of 2.40%. Overall, while the top-line performance is promising, challenges in profitability and efficiency may impact future sustainability.

Shivalik Rasayan Ltd's latest results present a mixed picture. On the positive side, the company reported a consolidated net profit of ₹4.53 crore for Q4 FY26, which is a significant increase of 67.78% quarter-on-quarter and 9.69% year-on-year. Additionally, net sales reached ₹102.82 crore, marking a robust growth of 25.33% from the previous quarter and an impressive 48.18% increase compared to the same quarter last year. This strong revenue growth suggests a recovery in market demand and operational momentum.<BR><BR>However, there are notable concerns. The operating margin for Q4 FY26 was 12.09%, which is slightly down from the previous quarter and significantly lower than historical highs. The return on equity (ROE) remains weak at just 2.40%, indicating challenges in generating adequate returns on shareholder capital. Furthermore, the company's stock has experienced a dramatic decline of 49.75% over the past year, reflecting broader market skepticism about its operational efficiency and profitability.<BR><BR>Overall, while the recent results show strong top-line growth, persistent margin pressures and low capital efficiency raise questions about the sustainability of this performance. Investors should weigh these factors carefully when assessing the company's outlook.

Is Shivalik Rasayan overvalued or undervalued?

As of December 3, 2025, Shivalik Rasayan is considered overvalued due to a high PE ratio of 44.34, an EV to EBITDA of 16.07, a low ROE of 2.40%, and significant underperformance compared to the Sensex, leading to a shift in its valuation grade from very attractive to attractive.

As of 3 December 2025, the valuation grade for Shivalik Rasayan has moved from very attractive to attractive, indicating a shift in perceived value. The company is currently considered overvalued based on its high PE ratio of 44.34, an EV to EBITDA of 16.07, and a low ROE of 2.40%. In comparison, peers such as Godrej Industries, which has a PE ratio of 36.37 and an EV to EBITDA of 40.25, suggest that Shivalik Rasayan's valuation is on the higher end within its industry.<BR><BR>The company's financial performance also shows concerning trends, with a significant decline in stock performance relative to the Sensex over various periods, particularly a year-to-date drop of 48.36% compared to the Sensex's gain of 8.92%. This underperformance, combined with the high valuation ratios, reinforces the conclusion that Shivalik Rasayan is overvalued in the current market environment.

How has been the historical performance of Shivalik Rasayan?

Shivalik Rasayan has shown consistent growth in net sales, reaching 311.77 Cr in Mar'25, but has faced fluctuations in operating profit and a decline in profit after tax from 34.25 Cr in Mar'22 to 20.42 Cr in Mar'25. Total liabilities and assets both increased to 727.73 Cr in Mar'25, while cash flow from operating activities remains negative.

Answer:<BR>The historical performance of Shivalik Rasayan shows a consistent growth trend in net sales and total operating income over the years, reaching 311.77 Cr in Mar'25, up from 272.98 Cr in Mar'24 and 234.45 Cr in Mar'23. However, the company has faced fluctuations in operating profit, with a peak of 50.46 Cr in Mar'22, followed by a decline to 48.51 Cr in Mar'25. Profit after tax has also seen a decrease, from 34.25 Cr in Mar'22 to 20.42 Cr in Mar'25. The company's total liabilities increased to 727.73 Cr in Mar'25 from 688.42 Cr in Mar'24, while total assets rose to 727.73 Cr as well, indicating a stable asset-liability balance. Cash flow from operating activities has been negative in recent years, with -9.00 Cr in Mar'25, reflecting challenges in cash generation despite positive financing activities.<BR><BR>Breakdown:<BR>Shivalik Rasayan's net sales and total operating income have shown a steady increase, with net sales rising from 186.28 Cr in Mar'20 to 311.77 Cr in Mar'25. The raw material costs have also increased significantly, contributing to total expenditure growth from 147.29 Cr in Mar'19 to 271.57 Cr in Mar'25. Operating profit, while fluctuating, peaked at 50.46 Cr in Mar'22 before declining to 48.51 Cr in Mar'25. Profit before tax has been relatively stable, with a slight increase to 23.41 Cr in Mar'25. However, profit after tax has decreased from 34.25 Cr in Mar'22 to 20.42 Cr in Mar'25. The company's total liabilities have risen alongside total assets, both reaching 727.73 Cr in Mar'25, indicating a balanced growth in financial structure. Cash flow from operating activities has been negative, highlighting ongoing challenges in cash generation despite positive inflows from financing activities.

Is Shivalik Rasayan technically bullish or bearish?

As of November 13, 2025, the technical trend is bearish with moderate strength, driven by bearish signals from moving averages and Bollinger Bands, despite a mildly bullish weekly MACD and Dow Theory outlook.

As of 13 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include the bearish signals from the daily moving averages, the weekly and monthly Bollinger Bands, and the KST. Although the weekly MACD shows a mildly bullish signal, it is overshadowed by the overall bearish trend in the monthly timeframe. Additionally, the Dow Theory indicates a mildly bullish weekly outlook but remains mildly bearish on the monthly scale. The stock has underperformed significantly compared to the Sensex over various periods, reinforcing the bearish sentiment.

Who are the top shareholders of the Shivalik Rasayan?

The top shareholders of Shivalik Rasayan are Growel Remedies Limited with 47.37%, individual investors with 30.62%, and Ginnerup Capital Aps holding 3.22%. There are no pledged promoter holdings, and mutual funds do not own shares in the company.

The top shareholders of Shivalik Rasayan include Growel Remedies Limited, which holds the largest stake at 47.37%. Additionally, individual investors collectively own 30.62% of the shares. Among public shareholders, Ginnerup Capital Aps has a notable holding of 3.22%. The company also has 15 foreign institutional investors (FIIs) that collectively hold 4.36% of the shares. There are no pledged promoter holdings, and mutual funds do not hold any shares in the company.

What is the bonus history of the Shivalik Rasayan?

Shivalik Rasayan issued a bonus in a 1:4 ratio on April 19, 2018, with a record date of April 20, 2018. This was the company's most recent bonus action.

Shivalik Rasayan has a bonus history that includes a significant issue announced on April 19, 2018. The company issued a bonus in the ratio of 1:4, meaning that for every four shares held, shareholders received one additional share. The record date for this bonus was April 20, 2018. This was the latest bonus action taken by the company. If you have any more questions about Shivalik Rasayan or need further details, feel free to ask!

Has Shivalik Rasayan declared dividend?

Shivalik Rasayan Ltd has declared a 10% dividend, amounting to ₹0.5 per share, with an ex-date of September 20, 2024. While the company has shown a strong total return of 121.13% over the last 5 years, recent shorter-term performance has been negative.

Shivalik Rasayan Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 0.5<BR>- Ex-date: 20 Sep 24<BR><BR>Dividend Yield: 0.09%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -30.22%, with a dividend return of 0%, resulting in a total return of -30.22%.<BR><BR>Over the past year, the price return was -6.13%, and the dividend return was 0.09%, leading to a total return of -6.04%.<BR><BR>In the 2-year period, the price return was -24.94%, with a dividend return of 0.13%, culminating in a total return of -24.81%.<BR><BR>For the 3-year period, the price return was -31.26%, while the dividend return was 0.21%, resulting in a total return of -31.05%.<BR><BR>In the 4-year period, the price return was -25.41%, with a dividend return of 0.25%, leading to a total return of -25.16%.<BR><BR>Finally, over the last 5 years, the price return was 120.38%, and the dividend return was 0.75%, resulting in a total return of 121.13%.<BR><BR>Overall, Shivalik Rasayan Ltd has declared a dividend, but the total returns over various periods show a mixed performance, with significant declines in the shorter terms and a strong recovery over the 5-year period.